Full article: Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement
![Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder - Leung - 2021 - Brain and Behavior - Wiley Online Library Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder - Leung - 2021 - Brain and Behavior - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/46848023-876e-4dd0-8c80-9ad6ad1b788f/brb32311-gra-0001-m.jpg)
Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder - Leung - 2021 - Brain and Behavior - Wiley Online Library
![PDF) A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study PDF) A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study](https://i1.rgstatic.net/publication/287372444_A_comparative_study_of_the_clinical_efficacy_and_safety_of_agomelatine_with_escitalopram_in_major_depressive_disorder_patients_A_randomized_parallel-group_phase_IV_study/links/57ec251c08ae92a5dbd06285/largepreview.png)
PDF) A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study
![PDF) Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder PDF) Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder](https://i1.rgstatic.net/publication/353632699_Drug_use_evaluation_A_two-year_retrospective_review_of_the_effectiveness_and_tolerability_of_agomelatine_versus_mirtazapine_in_patients_with_depressive_disorder/links/61076e170c2bfa282a15b72d/largepreview.png)
PDF) Drug use evaluation: A two‐year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder
![Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial | The British Journal of Psychiatry | Cambridge Core Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial | The British Journal of Psychiatry | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20180606105343-16438-mediumThumb-S0007125000240397_fig1g.jpg?pub-status=live)
Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial | The British Journal of Psychiatry | Cambridge Core
![A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study Urade CS, Mahakalkar SM, Tiple PG - J A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study Urade CS, Mahakalkar SM, Tiple PG - J](https://www.jpharmacol.com/articles/2015/6/4/images/JPharmacolPharmacother_2015_6_4_198_171883_f2.jpg)